首页> 美国卫生研究院文献>BMC Cancer >Carnitine palmitoyltransferase 1A (CPT1A): a transcriptional target of PAX3-FKHR and mediates PAX3-FKHR–dependent motility in alveolar rhabdomyosarcoma cells
【2h】

Carnitine palmitoyltransferase 1A (CPT1A): a transcriptional target of PAX3-FKHR and mediates PAX3-FKHR–dependent motility in alveolar rhabdomyosarcoma cells

机译:肉碱棕榈酰转移酶1A(CPT1A):PAX3-FKHR的转录靶标并介导肺泡横纹肌肉瘤细胞中依赖PAX3-FKHR的运动

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundAlveolar rhabdomyosarcoma (ARMS) has a high propensity to metastasize, leading to its aggressiveness and a poor survival rate among those with the disease. More than 80% of aggressive ARMSs harbor a PAX3-FKHR fusion transcription factor, which regulates cell migration and promotes metastasis, most likely by regulating the fusion protein’s transcriptional targets. Therefore, identifying druggable transcription targets of PAX3-FKHR that are also downstream effectors of PAX3-FKHR–mediated cell migration and metastasis may lead to novel therapeutic approaches for treating ARMS.
机译:背景肺泡横纹肌肉瘤(ARMS)具有很高的转移倾向,导致其侵略性和生存率低。超过80%的侵略性ARMS都带有PAX3-FKHR融合转录因子,该因子可调节细胞迁移并促进转移,很可能是通过调节融合蛋白的转录靶标来实现的。因此,鉴定也是PAX3-FKHR介导的细胞迁移和转移的下游效应物的PAX3-FKHR的可药物转录靶标,可能会导致治疗ARMS的新治疗方法。

著录项

相似文献

  • 外文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号